Cortical Deficits of Glutamic Acid Decarboxylase 67 Expression in Schizophrenia: Clinical, Protein, and Cell Type-Specific Features
Depression was associated with increased inflammation as measured by elevated levels of interleukin-6 and high-sensitivity C-reactive protein in patients with coronary heart disease, which was accounted for by the increased body mass index and cigarette smoking associated with depression. Objective:...
Saved in:
| Published in | The American journal of psychiatry Vol. 168; no. 9; pp. 921 - 929 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Arlington, VA
American Psychiatric Publishing
01.09.2011
American Psychiatric Association |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Depression was associated with increased inflammation as measured by elevated levels of interleukin-6 and high-sensitivity C-reactive protein in patients with coronary heart disease, which was accounted for by the increased body mass index and cigarette smoking associated with depression.
Objective:Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major γ-aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function.
Method:Quantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia.
Results:GAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%).
Conclusions:The findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia. |
|---|---|
| AbstractList | Depression was associated with increased inflammation as measured by elevated levels of interleukin-6 and high-sensitivity C-reactive protein in patients with coronary heart disease, which was accounted for by the increased body mass index and cigarette smoking associated with depression.
Objective:Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major γ-aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function.
Method:Quantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia.
Results:GAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%).
Conclusions:The findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia. OBJECTIVE: Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major gamma -aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function. METHOD: Quantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia. RESULTS: GAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%). CONCLUSIONS: The findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia. Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major γ-aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function.OBJECTIVECognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major γ-aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function.Quantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia.METHODQuantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia.GAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%).RESULTSGAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%).The findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia.CONCLUSIONSThe findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia. Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major γ-aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function. Quantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia. GAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%). The findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia. Objective: Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression of the 67 kDa isoform of glutamic acid decarboxylase (GAD67), the major [gamma]-aminobutyric acid (GABA)-synthesizing enzyme. However, little is known about the relationship of prefrontal GAD67 mRNA levels and illness severity, translation of the transcript into protein, and protein levels in axon terminals, the key site of GABA production and function. Method: Quantitative polymerase chain reaction was used to measure GAD67 mRNA levels in postmortem specimens of dorsolateral prefrontal cortex from subjects with schizophrenia and matched comparison subjects with no known history of psychiatric or neurological disorders (N=42 pairs). In a subset of this cohort in which potential confounds of protein measures were controlled (N=19 pairs), Western blotting was used to quantify tissue levels of GAD67 protein in tissue. In five of these pairs, multilabel confocal immunofluorescence was used to quantify GAD67 protein levels in the axon terminals of parvalbumin-containing GABA neurons, which are known to have low levels of GAD67 mRNA in schizophrenia. Results: GAD67 mRNA levels were significantly lower in schizophrenia subjects (by 15%), but transcript levels were not associated with predictors or measures of illness severity or chronicity. In schizophrenia subjects, GAD67 protein levels were significantly lower in total gray matter (by 10%) and in parvalbumin axon terminals (by 49%). Conclusions: The findings that lower GAD67 mRNA expression is common in schizophrenia, that it is not a consequence of having the illness, and that it leads to less translation of the protein, especially in the axon terminals of parvalbumin-containing neurons, support the hypothesis that lower GABA synthesis in parvalbumin neurons contributes to dorsolateral prefrontal cortex dysfunction and impaired cognition in schizophrenia. [PUBLICTION ABSTRACT] |
| Author | Sampson, Allan R. Lewis, David A. Curley, Allison A. Fish, Kenneth N. Asafu-Adjei, Josephine K. Volk, David W. Arion, Dominique |
| Author_xml | – sequence: 1 givenname: Allison A. surname: Curley fullname: Curley, Allison A. email: lewisda@upmc.edu – sequence: 2 givenname: Dominique surname: Arion fullname: Arion, Dominique email: lewisda@upmc.edu – sequence: 3 givenname: David W. surname: Volk fullname: Volk, David W. email: lewisda@upmc.edu – sequence: 4 givenname: Josephine K. surname: Asafu-Adjei fullname: Asafu-Adjei, Josephine K. email: lewisda@upmc.edu – sequence: 5 givenname: Allan R. surname: Sampson fullname: Sampson, Allan R. email: lewisda@upmc.edu – sequence: 6 givenname: Kenneth N. surname: Fish fullname: Fish, Kenneth N. email: lewisda@upmc.edu – sequence: 7 givenname: David A. surname: Lewis fullname: Lewis, David A. email: lewisda@upmc.edu |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24484610$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21632647$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEUhoNU7Lb6F0oQxJvOmo-ZJCMilO2HQkGhFbwLmSTjZplNxmRGut72j5vtblftzV6F5Dzvm5yT9wgc-OAtACcYTTHm7J3qezdVi35KEMb5CGGEKvIMTHBFq4ITIg7ABCFEirqi3w_BUUqLvEWUkxfgkGBGCSv5BNzPQhycVh08t63TbkgwtPCqGwe1dBqeaWdyRavYhLtVp5KFjMOLuz7alFzw0Hl4o-fud-jn0Xqn3sNZ5_za8BR-jWGwzp9C5Q2c2a6Dt6veFje91S7fBS-tGsZs9BI8b1WX7Kvtegy-XV7czj4V11-uPs_OrgtVsXIo2qYxpqKt5a2hFJcVJ9goLHiNlRWEWtXUSBjTGlZbVhHLypbRhpYKUytqQ4_Bx41vPzZLa7T1Q1Sd7KNbqriSQTn5f8W7ufwRfklKOOUCZYO3W4MYfo42DXLpks6NKW_DmGSNOOacVWwvKQTnFa-5yOTrJ-QijNHnOWRI0JKUD9DJvy_fPfnxHzPwZguolGffRuW1S3-5shQlw-sO2IbTMaQUbbtDMJLrYMl1sGQOllwHSz4GKws_PBHmrKghRyBPynX75XQjf6jvOtyj-gNuleeJ |
| CODEN | AJPSAO |
| CitedBy_id | crossref_primary_10_1111_gbb_12188 crossref_primary_10_1017_S0033291719003325 crossref_primary_10_3389_fncel_2024_1440834 crossref_primary_10_1016_j_biopsych_2015_03_030 crossref_primary_10_1113_jphysiol_2011_224659 crossref_primary_10_1038_tp_2012_111 crossref_primary_10_3892_mmr_2025_13479 crossref_primary_10_3389_fneur_2021_745159 crossref_primary_10_1176_appi_ajp_2014_14010004 crossref_primary_10_1038_mp_2017_105 crossref_primary_10_3389_fncel_2023_1161608 crossref_primary_10_1007_s00429_018_1769_z crossref_primary_10_1093_schbul_sbz046 crossref_primary_10_1016_j_neuroscience_2014_12_013 crossref_primary_10_1093_brain_awaa178 crossref_primary_10_1038_s41598_017_11645_8 crossref_primary_10_1038_npp_2016_24 crossref_primary_10_3389_fnmol_2018_00270 crossref_primary_10_1038_s41598_020_58449_x crossref_primary_10_3389_fpsyt_2017_00118 crossref_primary_10_1016_j_psychres_2014_09_016 crossref_primary_10_1016_j_bbr_2016_10_012 crossref_primary_10_1089_can_2022_0183 crossref_primary_10_1097_FBP_0000000000000360 crossref_primary_10_1016_j_neuropharm_2020_108103 crossref_primary_10_3389_fpsyt_2021_679960 crossref_primary_10_1007_s12272_019_01196_z crossref_primary_10_1038_npp_2014_95 crossref_primary_10_1093_schbul_sbv136 crossref_primary_10_1016_j_schres_2016_02_018 crossref_primary_10_1176_appi_ajp_2011_11050694 crossref_primary_10_3389_fnana_2018_00009 crossref_primary_10_1038_s41582_023_00904_0 crossref_primary_10_1016_j_jpsychires_2017_03_008 crossref_primary_10_1038_s42003_024_06391_3 crossref_primary_10_1016_j_xcrm_2022_100597 crossref_primary_10_1093_cercor_bhv051 crossref_primary_10_3389_fncel_2017_00158 crossref_primary_10_1002_jdn_10175 crossref_primary_10_1155_2021_9983438 crossref_primary_10_1016_j_biopsych_2012_04_010 crossref_primary_10_1016_j_conb_2017_08_012 crossref_primary_10_1007_s00213_014_3816_7 crossref_primary_10_1038_s41380_021_01037_w crossref_primary_10_1176_appi_ajp_2012_12030305 crossref_primary_10_1016_j_euroneuro_2013_11_009 crossref_primary_10_1016_j_lfs_2022_120526 crossref_primary_10_1016_j_schres_2014_10_011 crossref_primary_10_1016_j_neuropharm_2016_09_022 crossref_primary_10_1016_j_biopsych_2015_07_022 crossref_primary_10_1016_j_biopsych_2014_05_010 crossref_primary_10_1016_j_ijdevneu_2018_07_001 crossref_primary_10_1111_j_1460_9568_2012_08156_x crossref_primary_10_1016_j_neuropharm_2012_09_009 crossref_primary_10_1111_iep_12222 crossref_primary_10_1016_j_biopsych_2023_04_003 crossref_primary_10_31887_DCNS_2013_15_3_puhlhaas crossref_primary_10_1016_j_neuroscience_2013_06_008 crossref_primary_10_1016_j_schres_2015_01_025 crossref_primary_10_1016_j_schres_2014_10_020 crossref_primary_10_1177_15500594221148643 crossref_primary_10_3389_fnana_2021_670766 crossref_primary_10_1021_pr500719f crossref_primary_10_1093_schbul_sbt178 crossref_primary_10_1016_j_biopsych_2018_01_022 crossref_primary_10_1016_j_biopsych_2013_09_019 crossref_primary_10_1186_1471_244X_13_107 crossref_primary_10_1016_j_conb_2011_05_013 crossref_primary_10_1016_j_schres_2017_07_021 crossref_primary_10_1093_cercor_bhy227 crossref_primary_10_1038_mp_2013_49 crossref_primary_10_1016_j_schres_2014_10_031 crossref_primary_10_1111_jnc_12061 crossref_primary_10_1016_j_biopsych_2016_09_017 crossref_primary_10_1093_schbul_sbz123 crossref_primary_10_1016_j_biopsych_2016_09_018 crossref_primary_10_1016_j_conb_2013_11_003 crossref_primary_10_1016_j_nbd_2012_11_013 crossref_primary_10_1016_j_biopsych_2024_05_014 crossref_primary_10_1016_j_biopsych_2017_10_032 crossref_primary_10_1016_j_tins_2016_10_009 crossref_primary_10_1631_jzus_B2300743 crossref_primary_10_1371_journal_pone_0121744 crossref_primary_10_1111_apha_13282 crossref_primary_10_1038_mp_2015_141 crossref_primary_10_1016_j_neuropharm_2011_11_022 crossref_primary_10_1016_j_neubiorev_2018_07_001 crossref_primary_10_1176_appi_ajp_2015_15010019 crossref_primary_10_3389_fncel_2018_00284 crossref_primary_10_1016_j_schres_2013_02_038 crossref_primary_10_1016_j_mcn_2022_103733 crossref_primary_10_1016_j_biopsych_2014_01_001 crossref_primary_10_1016_j_biopsych_2015_03_010 crossref_primary_10_1176_appi_ajp_2021_21080798 crossref_primary_10_3389_fncel_2022_992409 crossref_primary_10_1016_j_biopsych_2016_05_022 crossref_primary_10_1177_0269881120922963 crossref_primary_10_1007_s00406_012_0367_y crossref_primary_10_1007_s11064_013_0977_4 crossref_primary_10_1186_s13041_020_00713_2 crossref_primary_10_1038_mp_2014_35 crossref_primary_10_1016_j_bbi_2012_01_015 crossref_primary_10_1016_j_schres_2019_06_003 crossref_primary_10_3389_fnbeh_2016_00059 crossref_primary_10_1016_j_neuron_2015_01_019 crossref_primary_10_7759_cureus_26745 crossref_primary_10_1016_j_euroneuro_2016_12_001 crossref_primary_10_1002_2211_5463_13065 crossref_primary_10_1016_j_pnpbp_2017_03_018 crossref_primary_10_1016_j_schres_2018_09_010 crossref_primary_10_1017_S0033291716001446 crossref_primary_10_1016_j_biopsych_2023_03_020 crossref_primary_10_3389_fnins_2023_1358271 crossref_primary_10_1093_ijnp_pyu013 crossref_primary_10_1038_s41398_018_0119_5 crossref_primary_10_1016_j_biopsych_2022_12_004 crossref_primary_10_1016_j_tins_2011_10_004 crossref_primary_10_1016_j_nbd_2013_07_008 crossref_primary_10_1152_jn_00523_2018 crossref_primary_10_3390_biom15010056 crossref_primary_10_1152_jn_00126_2014 crossref_primary_10_1186_s12888_025_06584_y crossref_primary_10_1016_j_schres_2020_06_032 crossref_primary_10_1016_j_biopsych_2021_02_009 crossref_primary_10_1016_j_nbd_2012_10_018 crossref_primary_10_1016_j_neuropharm_2016_08_038 crossref_primary_10_1093_hmg_ddu285 crossref_primary_10_1016_j_schres_2019_10_007 crossref_primary_10_1016_j_neulet_2012_09_032 crossref_primary_10_3390_ijms22147510 crossref_primary_10_3390_ijms22063274 crossref_primary_10_1093_nar_gkv1304 crossref_primary_10_1016_j_psyneuen_2018_02_024 crossref_primary_10_1038_mp_2016_147 crossref_primary_10_1177_02698811221078751 crossref_primary_10_3389_fpsyt_2019_00835 crossref_primary_10_1038_mp_2015_222 crossref_primary_10_1038_s41398_019_0660_x crossref_primary_10_1016_j_neuron_2013_07_010 crossref_primary_10_1038_s41398_020_01108_6 crossref_primary_10_1007_s10827_024_00884_0 crossref_primary_10_1038_mp_2013_152 crossref_primary_10_1016_j_pnpbp_2013_10_015 crossref_primary_10_1038_mp_2014_192 crossref_primary_10_1371_journal_pone_0066327 crossref_primary_10_3109_01677063_2013_878339 crossref_primary_10_1038_s41380_020_0711_y crossref_primary_10_1002_epi4_12062 crossref_primary_10_1016_j_pbb_2015_05_019 crossref_primary_10_1111_pcn_13300 crossref_primary_10_1016_j_biopsych_2014_06_026 crossref_primary_10_1016_j_neulet_2018_08_010 crossref_primary_10_3389_fphar_2021_646088 crossref_primary_10_1016_j_pneurobio_2015_10_002 crossref_primary_10_1038_s41386_021_01089_0 crossref_primary_10_1016_j_neuropharm_2017_06_018 crossref_primary_10_1097_YCT_0000000000000507 crossref_primary_10_3389_fpsyt_2019_00013 crossref_primary_10_1038_s41386_018_0260_0 crossref_primary_10_1016_j_neubiorev_2024_105699 crossref_primary_10_1038_mp_2014_66 crossref_primary_10_1016_j_bionps_2020_100015 crossref_primary_10_1007_s00702_014_1194_2 crossref_primary_10_1016_j_neuropharm_2019_107844 crossref_primary_10_3389_fpsyt_2018_00281 crossref_primary_10_3389_fnins_2021_677153 crossref_primary_10_1007_s00213_017_4670_1 crossref_primary_10_1176_appi_ajp_2015_15020150 crossref_primary_10_1016_j_nbd_2018_06_020 crossref_primary_10_1038_s41398_023_02469_4 crossref_primary_10_1016_j_neubiorev_2015_04_014 crossref_primary_10_1038_s41398_020_0853_3 crossref_primary_10_1176_appi_ajp_2012_12070940 crossref_primary_10_1016_j_schres_2016_03_001 crossref_primary_10_1016_j_jpsychires_2019_04_014 crossref_primary_10_1038_s41537_019_0078_8 crossref_primary_10_1016_j_neuro_2017_10_006 crossref_primary_10_1016_j_jpsychires_2015_02_006 crossref_primary_10_1176_appi_ajp_2016_16010025 crossref_primary_10_1038_s41386_023_01576_6 crossref_primary_10_1016_j_biopsych_2022_03_002 crossref_primary_10_1016_j_euroneuro_2011_08_001 crossref_primary_10_1016_j_bpsc_2020_02_004 crossref_primary_10_1111_gbb_12315 crossref_primary_10_1016_j_neulet_2019_134615 crossref_primary_10_1038_s41398_019_0436_3 crossref_primary_10_1016_j_neuropharm_2019_107704 crossref_primary_10_1007_s11481_012_9417_5 crossref_primary_10_1080_15332985_2014_894487 crossref_primary_10_1093_schbul_sbw022 crossref_primary_10_3389_fpsyt_2018_00537 crossref_primary_10_1016_j_conb_2014_08_009 crossref_primary_10_1016_j_neubiorev_2023_105488 crossref_primary_10_1038_mp_2017_25 crossref_primary_10_1159_000448244 crossref_primary_10_1126_sciadv_aau8237 crossref_primary_10_1176_appi_ajp_20220147 crossref_primary_10_1038_s41380_024_02417_8 crossref_primary_10_1097_YCO_0000000000000244 crossref_primary_10_1093_cercor_bhr202 crossref_primary_10_1016_j_nbd_2011_12_008 crossref_primary_10_1016_j_biopsych_2015_06_015 crossref_primary_10_1016_j_nbd_2016_12_019 crossref_primary_10_1016_j_conb_2023_102820 crossref_primary_10_1176_appi_ajp_2013_13040468 crossref_primary_10_1016_j_nbd_2013_11_001 crossref_primary_10_1038_s41380_025_02909_1 crossref_primary_10_1093_schbul_sbu068 crossref_primary_10_31887_DCNS_2014_16_3_sakbarian |
| Cites_doi | 10.1001/archpsyc.1986.01800020020004 10.1523/JNEUROSCI.18-11-04244.1998 10.1006/bbrc.1996.1898 10.1001/archpsyc.57.11.1061 10.1093/schbul/sbm046 10.1038/npp.2010.156 10.1146/annurev.neuro.24.1.167 10.1016/j.brainres.2008.08.060 10.1038/nrn1648 10.1073/pnas.94.12.6496 10.1038/nature08002 10.1007/BF00249897 10.1001/archpsyc.57.3.237 10.1001/archgenpsychiatry.2009.91 10.1523/JNEUROSCI.4035-04.2005 10.1001/archpsyc.65.7.772 10.1002/hup.1070 10.1176/appi.ajp.2007.07081223 10.1523/JNEUROSCI.23-15-06315.2003 10.1176/ajp.153.3.321 10.1038/npp.2008.67 10.1001/archpsyc.1995.03950160008002 10.1093/cercor/4.1.40 10.1016/S0891-0618(00)00105-8 10.1016/j.biopsych.2010.09.038 10.1093/schbul/sbn070 10.1038/sj.mp.4002011 10.1038/npp.2010.150 10.1016/j.schres.2009.04.026 10.1111/j.1471-4159.2006.03741.x 10.1523/JNEUROSCI.6158-09.2010 10.1073/pnas.0609440103 10.1111/j.1471-4159.1993.tb03206.x 10.1111/j.1749-6632.2002.tb02083.x 10.1016/j.biopsych.2010.05.016 10.1007/s11920-010-0124-8 10.1097/01.jnen.0000240474.27791.f3 10.1016/S0006-8993(01)02778-0 10.1093/nar/gni054 |
| ContentType | Journal Article |
| Copyright | Copyright © American Psychiatric Association 2011 2015 INIST-CNRS Copyright © American Psychiatric Association |
| Copyright_xml | – notice: Copyright © American Psychiatric Association 2011 – notice: 2015 INIST-CNRS – notice: Copyright © American Psychiatric Association |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 7TK 5PM |
| DOI | 10.1176/appi.ajp.2011.11010052 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitleList | Neurosciences Abstracts MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1535-7228 |
| EndPage | 929 |
| ExternalDocumentID | PMC3273780 2448419131 21632647 24484610 10_1176_appi_ajp_2011_11010052 10.1176/appi.ajp.2011.11010052 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIMH NIH HHS grantid: R01 MH043784 – fundername: NIMH NIH HHS grantid: R21 MH085108 – fundername: NIMH NIH HHS grantid: R37 MH043784 – fundername: NIMH NIH HHS grantid: K08 MH084016 – fundername: NIMH NIH HHS grantid: MH-084016 – fundername: NIMH NIH HHS grantid: P50 MH084053 – fundername: NIMH NIH HHS grantid: MH-084053 – fundername: NIMH NIH HHS grantid: MH-043784 – fundername: NIMH NIH HHS grantid: MH-085108 – fundername: National Institute of Mental Health : NIMH grantid: P50 MH084053-05 || MH – fundername: National Institute of Mental Health : NIMH grantid: K08 MH084016-04 || MH – fundername: National Institute of Mental Health : NIMH grantid: R37 MH043784-21 || MH – fundername: National Institute of Mental Health : NIMH grantid: R21 MH085108-02 || MH |
| GroupedDBID | --- --Z -DZ -~X .55 .GJ 08P 0WA 1CY 1HT 1KJ 1QT 23M 2QL 2WC 354 3O- 4.4 41~ 53G 5GY 5RE 6J9 6TJ 7K8 85S 8F7 8R4 8R5 AAAHA AAIKC AAJMC AAJWC AAKAS AAMNW AAQQT AAWTL AAWTO AAYJJ ABIVO ABPPZ ABZEH ACBMB ACGFO ACGOD ACHQT ACNCT ADBBV ADCOW ADZCM AENEX AERZD AETEA AFAZI AFFDN AFFNX AFMIJ AFOSN AGHSJ AGNAY AHJKT AHMBA AI. AIZTS ALMA_UNASSIGNED_HOLDINGS ASUFR BAJDF BAWUL BCR BENPR BKOMP BLC CS3 DIK E3Z EBS EJD EX3 F20 F5P F8P FA8 FJW G0H G8K GOZPB GRPMH HF~ HZ~ J5H L7B LPU LXL LXN MVM N4W N9A NEJ NHB OHT OK1 OVD P-O P2P PEA PQQKQ Q.- Q2X RAY RWL RXW RYA S10 SJN SKT TAE TEORI TR2 TWZ UBC UHB UKR ULE UPT UQL VH1 VVN WH7 WHG WOQ WOW X4V X6Y X7M XJT XOL XSW XZL YCJ YFH YOC YQI YQJ YRY YSK YWH YXB YYQ YZZ ZCA ZGI ZHY ZKB ZRR ZXP ZY1 ~A~ ~G0 ~X8 AAYXX ABDPE ADGHP ADMHG CITATION H13 IQODW CGR CUY CVF ECM EIF NPM ADXHL K9. NAPCQ 7X8 7TK 5PM |
| ID | FETCH-LOGICAL-a564t-fbbdd53fe7fd33145721da18791ae823eab908ddfd69e652e64f63b34a13e89d3 |
| ISSN | 0002-953X 1535-7228 |
| IngestDate | Thu Aug 21 18:25:51 EDT 2025 Fri Jul 11 03:39:45 EDT 2025 Thu Jul 10 16:57:22 EDT 2025 Wed Aug 13 08:10:34 EDT 2025 Mon Jul 21 06:06:49 EDT 2025 Mon Jul 21 09:18:09 EDT 2025 Thu Apr 24 23:00:24 EDT 2025 Tue Jul 01 01:51:37 EDT 2025 Wed Jul 24 08:10:56 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | Psychosis Carbon-carbon lyases Enzyme Carboxy-lyases Schizophrenia Lyases Glutamate decarboxylase Protein |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a564t-fbbdd53fe7fd33145721da18791ae823eab908ddfd69e652e64f63b34a13e89d3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| PMID | 21632647 |
| PQID | 888342478 |
| PQPubID | 40661 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3273780 proquest_miscellaneous_907177656 proquest_miscellaneous_887757978 proquest_journals_888342478 pubmed_primary_21632647 pascalfrancis_primary_24484610 crossref_primary_10_1176_appi_ajp_2011_11010052 crossref_citationtrail_10_1176_appi_ajp_2011_11010052 appi_journals_10_1176_appi_ajp_2011_11010052 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-09-01 |
| PublicationDateYYYYMMDD | 2011-09-01 |
| PublicationDate_xml | – month: 09 year: 2011 text: 2011-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Arlington, VA |
| PublicationPlace_xml | – name: Arlington, VA – name: United States – name: Washington |
| PublicationTitle | The American journal of psychiatry |
| PublicationTitleAlternate | Am J Psychiatry |
| PublicationYear | 2011 |
| Publisher | American Psychiatric Publishing American Psychiatric Association |
| Publisher_xml | – name: American Psychiatric Publishing – name: American Psychiatric Association |
| References | Zaborski, P 2005; 33 Reinking, C 2010; 35 Hashimoto, T 2008; 65 Matsumura, M 1989; 75 Martin, DL 1993; 60 Sanbo, M 1997; 94 Maldonado-Avilés, JG 2008; 13 Hagman, JO 1995; 52 Pandey, G 2000; 57 Imbeaud, S 2005; 33 Cho, RY 2006; 103 Volk, DW 2000; 57 Auta, J 2000; 57 Rimvall, K 1993; 60 Hayashi, K 2009; 112 Ji, FY 1996; 229 Deisseroth, K 2009; 459 Lewis, DA 2008; 1240 Kawamura, Y 1997; 94 Obata, K 1997; 94 Korogi, Y 2009; 24 Martin, DL 2001; 914 Lewis, DA 2008; 13 Yoshimura, R 2009; 24 Umene-Nakano, W 2009; 24 Gonzalez-Burgos, G 2008; 34 Bertrand, O 1998; 18 Bergen, SE 2005; 25 Eggan, SM 2003; 23 Hashimoto, T 2003; 23 Nakamura, J 2009; 112 Silver, MA 2010; 30 Minzenberg, MJ 2011; 36 Laird, AR 2009; 66 Pierri, JN 2005; 25 Carter, CS 2011; 36 Pesold, C 2000; 57 Battaglioli, G 2006; 97 Hayashi, K 2009; 24 Huntsman, MM 1994; 4 Impagnatiello, F 2000; 57 Maruyama, K 1997; 94 Moriya, J 2009; 112 Martin, DL 2006; 97 Mueller, O 2005; 33 Schroeder, A 2005; 33 McCarthy, J 2010; 68 Sanbo, M 1996; 229 Jones, EG 1994; 4 Guidotti, A 2000; 57 Mirnics, K 2003; 23 Cohen, JD 2001; 24 Knoblich, U 2009; 459 Konecky, RO 2006; 103 Davis, JM 2000; 57 Sun, Z 2003; 23 Yagi, T 1997; 94 Rothman, DL 2001; 914 Kume, H 1997; 94 Ueda, N 2009; 112 Barlet, X 2005; 33 Williams, M 2000; 20 Di-Giorgi-Gerevini, V 2000; 57 Boulanger, V 2005; 33 Gomes, GC 2010; 35 Lewis, DA 2008; 34 Sheikh, SN 1993; 60 Goto, N 2009; 112 Nguyen, QL 2005; 25 Sawaguchi, T 1989; 75 Eggan, SM 2008; 65 Sampson, AR 2005; 25 Ikenouchi-Sugita, A 2009; 24 Tse, MT 2011; 69 Potkin, SG 1995; 52 Sweet, RA 2008; 1240 Ongur, D 2010; 68 Maddock, RJ 2010; 30 Lesh, TA 2011; 36 Asada, H 1996; 229 Ikenouchi-Sugita, A 2009; 112 Dwivedi, Y 2000; 57 Martin, SB 2001; 914 Cardin, JA 2009; 459 Zhang, F 2009; 459 Lewis, DA 2005; 25 Tafazzoli, A 1995; 52 Eveno, E 2005; 33 Ragland, JD 2010; 30 Oonari, N 2009; 112 Benes, FM 2000; 20 Akbarian, S 1995; 52 Korogi, Y 2009; 112 Kume, H 1996; 229 Carter, CS 2010; 30 Patel, A 2001; 914 Todtenkopf, MS 2000; 20 Carter, CS 2009; 66 Carter, CS 2010; 35 Wu, Q 2008; 165 Austin, MC 2000; 57 Lewis, DA 2010; 12 Keller, JN 2007; 66 Volk, DW 2003; 23 Ueda, N 2009; 24 Bunney, WE 1995; 52 Logiotatos, P 2000; 20 Bazmi, HH 2008; 165 Sampson, AR 2008; 165 Kim, JJ 1995; 52 Nakamura, J 2009; 24 Lewis, DA 2009; 34 Benson, DL 1994; 4 Volk, DW 2005; 6 Nelson, PT 2007; 66 Green, MF 1996; 153 Volk, DW 2008; 13 Firl, AJ 2010; 35 Fish, KN 2008; 1240 Niendam, TA 2011; 36 Keefe, RS 2007; 33 Unger, T 2008; 13 Gonzalez-Burgos, G 2010; 12 Tsai, LH 2009; 459 Porta, EA 2002; 959 Manor, D 2001; 914 Mason, GF 2001; 914 Lewis, DA 2000; 57 Hashimoto, T 2005; 6 Hori, H 2009; 24 Berman, KF 1986; 43 Behar, KL 2006; 97 Sharma, R 2000; 57 Moore, CI 2009; 459 Tallon-Baudry, C 1998; 18 Yoshimura, R 2009; 112 Thelen, S 2009; 66 Lewis, DA 2003; 23 Cohen, BM 2010; 68 de Graaf, RA 2006; 97 Grayson, DR 2000; 57 Sun, Z 2005; 25 Jones, EG 1995; 52 Carlén, M 2009; 459 Hashimoto, T 2005; 25 Ding, R 1996; 229 Behar, KL 2001; 914 Hashimoto, T 2008; 165 Miller, EK 2001; 24 Enomoto, T 2011; 69 Patel, AB 2006; 97 Lewis, DA 2008; 165 Maruyama, K 1996; 229 Xu, B 2005; 25 Rokem, A 2010; 30 Kuzume, H 1996; 229 Renshaw, PF 2010; 68 Zhang, W 2009; 34 Kawamura, Y 1996; 229 Pernier, J 1998; 18 Auffray, C 2005; 33 Floresco, SB 2011; 69 Sibson, NR 2001; 914 Umene-Nakano, W 2009; 112 Asada, H 1997; 94 Zec, RF 1986; 43 Yagi, T 1996; 229 Lewis, DA 2008; 65 Carter, CS 2006; 103 Sampson, AR 2009; 34 Morris, HM 2008; 13 Pierri, JN 2003; 23 Sampson, AR 2003; 23 Sampson, AR 2000; 57 Hashimoto, T 2008; 13 Obata, K 1996; 229 Kuzume, H 1997; 94 Arion, D 2008; 13 Kanbara, N 1997; 94 Weinberger, DR 1986; 43 Yoon, JH 2010; 30 Glahn, DC 2009; 66 Yoon, JH 2010; 35 Meletis, K 2009; 459 Ding, RG 1997; 94 Kanbara, N 1996; 229 Mirnics, K 2008; 13 Kakeda, S 2009; 112 Kakeda, S 2009; 24 Peronnet, F 1998; 18 Minzenberg, MJ 2009; 66 Goto, N 2009; 24 Uzunov, D 2000; 57 Costa, E 2000; 57 Fenton, WS 2007; 33 Monteggia, LM 2005; 25 Mirnics, K 2008; 165 Sweet, RA 2009; 34 Prescot, AP 2010; 68 Kubota, K 1989; 75 Deo, AJ 2008; 1240 Minzenberg, MJ 2010; 35 Graudens, E 2005; 33 Moriya, J 2009; 24 Henteleff, RA 2009; 34 Lewis, DA 2005; 6 Hashimoto, T 2010; 12 Pierri, JN 2000; 57 Minzenberg, MJ 2010; 30 B20 B22 B23 B24 B25 B26 B27 B28 B29 B30 Beneyto M (B21) 2008 B31 B10 B32 B11 B12 Hollingshead AB (B33) 1965 B34 B13 B35 B14 B36 B15 B37 B16 B38 B17 B39 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 B40 B41 21890799 - Am J Psychiatry. 2011 Sep;168(9):879-81. doi: 10.1176/appi.ajp.2011.11050694. |
| References_xml | – volume: 103 start-page: 19878 year: 2006 end-page: 19883 article-title: Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia publication-title: Proc Natl Acad Sci USA – volume: 12 start-page: 335 year: 2010 end-page: 344 article-title: Alterations of cortical GABA neurons and network oscillations in schizophrenia publication-title: Curr Psychiatry Rep – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 60 start-page: 714 year: 1993 end-page: 720 article-title: Effects of increased gamma-aminobutyric acid levels on GAD67 protein and mRNA levels in rat cerebral cortex publication-title: J Neurochem – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 12 start-page: 335 year: 2010 end-page: 344 article-title: Alterations of cortical GABA neurons and network oscillations in schizophrenia publication-title: Curr Psychiatry Rep – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 75 start-page: 457 year: 1989 end-page: 469 article-title: Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys publication-title: Exp Brain Res – volume: 35 start-page: 2590 year: 2010 end-page: 2599 article-title: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia publication-title: Neuropsychopharmacology – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 35 start-page: 2590 year: 2010 end-page: 2599 article-title: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia publication-title: Neuropsychopharmacology – volume: 43 start-page: 114 year: 1986 end-page: 124 article-title: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence publication-title: Arch Gen Psychiatry – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 12 start-page: 335 year: 2010 end-page: 344 article-title: Alterations of cortical GABA neurons and network oscillations in schizophrenia publication-title: Curr Psychiatry Rep – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 34 start-page: 374 year: 2009 end-page: 389 article-title: Reduced dendritic spine density in auditory cortex of subjects with schizophrenia publication-title: Neuropsychopharmacology – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 165 start-page: 479 year: 2008 end-page: 489 article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 165 start-page: 479 year: 2008 end-page: 489 article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 34 start-page: 374 year: 2009 end-page: 389 article-title: Reduced dendritic spine density in auditory cortex of subjects with schizophrenia publication-title: Neuropsychopharmacology – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 36 start-page: 316 year: 2011 end-page: 338 article-title: Cognitive control deficits in schizophrenia: mechanisms and meaning publication-title: Neuropsychopharmacology – volume: 18 start-page: 4244 year: 1998 end-page: 4254 article-title: Induced gamma-band activity during the delay of a visual short-term memory task in humans publication-title: J Neurosci – volume: 35 start-page: 2590 year: 2010 end-page: 2599 article-title: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia publication-title: Neuropsychopharmacology – volume: 97 start-page: 385 year: 2006 end-page: 396 article-title: Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo publication-title: J Neurochem – volume: 20 start-page: 259 year: 2000 end-page: 269 article-title: Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain publication-title: J Chem Neuroanat – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 57 start-page: 237 year: 2000 end-page: 245 article-title: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia publication-title: Arch Gen Psychiatry – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 34 start-page: 944 year: 2008 end-page: 961 article-title: GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia publication-title: Schizophr Bull – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 1240 start-page: 62 year: 2008 end-page: 72 article-title: An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections publication-title: Brain Res – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 60 start-page: 714 year: 1993 end-page: 720 article-title: Effects of increased gamma-aminobutyric acid levels on GAD67 protein and mRNA levels in rat cerebral cortex publication-title: J Neurochem – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 34 start-page: 374 year: 2009 end-page: 389 article-title: Reduced dendritic spine density in auditory cortex of subjects with schizophrenia publication-title: Neuropsychopharmacology – volume: 57 start-page: 237 year: 2000 end-page: 245 article-title: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia publication-title: Arch Gen Psychiatry – volume: 65 start-page: 772 year: 2008 end-page: 784 article-title: Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia publication-title: Arch Gen Psychiatry – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 6 start-page: 312 year: 2005 end-page: 324 article-title: Cortical inhibitory neurons and schizophrenia publication-title: Nat Rev Neurosci – volume: 35 start-page: 2590 year: 2010 end-page: 2599 article-title: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia publication-title: Neuropsychopharmacology – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 57 start-page: 237 year: 2000 end-page: 245 article-title: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia publication-title: Arch Gen Psychiatry – volume: 69 start-page: 432 year: 2011 end-page: 441 article-title: Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia publication-title: Biol Psychiatry – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 36 start-page: 316 year: 2011 end-page: 338 article-title: Cognitive control deficits in schizophrenia: mechanisms and meaning publication-title: Neuropsychopharmacology – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 165 start-page: 479 year: 2008 end-page: 489 article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 1240 start-page: 62 year: 2008 end-page: 72 article-title: An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections publication-title: Brain Res – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 34 start-page: 374 year: 2009 end-page: 389 article-title: Reduced dendritic spine density in auditory cortex of subjects with schizophrenia publication-title: Neuropsychopharmacology – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 165 start-page: 479 year: 2008 end-page: 489 article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 6 start-page: 312 year: 2005 end-page: 324 article-title: Cortical inhibitory neurons and schizophrenia publication-title: Nat Rev Neurosci – volume: 66 start-page: 811 year: 2009 end-page: 822 article-title: Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia publication-title: Arch Gen Psychiatry – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 20 start-page: 259 year: 2000 end-page: 269 article-title: Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain publication-title: J Chem Neuroanat – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 66 start-page: 811 year: 2009 end-page: 822 article-title: Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia publication-title: Arch Gen Psychiatry – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 18 start-page: 4244 year: 1998 end-page: 4254 article-title: Induced gamma-band activity during the delay of a visual short-term memory task in humans publication-title: J Neurosci – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 459 start-page: 663 year: 2009 end-page: 667 article-title: Driving fast-spiking cells induces gamma rhythm and controls sensory responses publication-title: Nature – volume: 4 start-page: 40 year: 1994 end-page: 51 article-title: Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys publication-title: Cereb Cortex – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 43 start-page: 114 year: 1986 end-page: 124 article-title: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence publication-title: Arch Gen Psychiatry – volume: 69 start-page: 432 year: 2011 end-page: 441 article-title: Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia publication-title: Biol Psychiatry – volume: 103 start-page: 19878 year: 2006 end-page: 19883 article-title: Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia publication-title: Proc Natl Acad Sci USA – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 68 start-page: 667 year: 2010 end-page: 670 article-title: Elevated gamma-aminobutyric acid levels in chronic schizophrenia publication-title: Biol Psychiatry – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 68 start-page: 667 year: 2010 end-page: 670 article-title: Elevated gamma-aminobutyric acid levels in chronic schizophrenia publication-title: Biol Psychiatry – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 153 start-page: 321 year: 1996 end-page: 330 article-title: What are the functional consequences of neurocognitive deficits in schizophrenia? publication-title: Am J Psychiatry – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 65 start-page: 772 year: 2008 end-page: 784 article-title: Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia publication-title: Arch Gen Psychiatry – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 20 start-page: 259 year: 2000 end-page: 269 article-title: Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain publication-title: J Chem Neuroanat – volume: 68 start-page: 667 year: 2010 end-page: 670 article-title: Elevated gamma-aminobutyric acid levels in chronic schizophrenia publication-title: Biol Psychiatry – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 66 start-page: 811 year: 2009 end-page: 822 article-title: Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia publication-title: Arch Gen Psychiatry – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 24 start-page: 167 year: 2001 end-page: 202 article-title: An integrative theory of prefrontal cortex function publication-title: Annu Rev Neurosci – volume: 36 start-page: 316 year: 2011 end-page: 338 article-title: Cognitive control deficits in schizophrenia: mechanisms and meaning publication-title: Neuropsychopharmacology – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 97 start-page: 385 year: 2006 end-page: 396 article-title: Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo publication-title: J Neurochem – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 35 start-page: 2590 year: 2010 end-page: 2599 article-title: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia publication-title: Neuropsychopharmacology – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 18 start-page: 4244 year: 1998 end-page: 4254 article-title: Induced gamma-band activity during the delay of a visual short-term memory task in humans publication-title: J Neurosci – volume: 75 start-page: 457 year: 1989 end-page: 469 article-title: Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys publication-title: Exp Brain Res – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 60 start-page: 714 year: 1993 end-page: 720 article-title: Effects of increased gamma-aminobutyric acid levels on GAD67 protein and mRNA levels in rat cerebral cortex publication-title: J Neurochem – volume: 33 start-page: 912 year: 2007 end-page: 920 article-title: How should DSM-V criteria for schizophrenia include cognitive impairment? publication-title: Schizophr Bull – volume: 97 start-page: 385 year: 2006 end-page: 396 article-title: Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo publication-title: J Neurochem – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 66 start-page: 461 year: 2007 end-page: 468 article-title: RNA in brain disease: no longer just “the messenger in the middle.” publication-title: J Neuropathol Exp Neurol – volume: 69 start-page: 432 year: 2011 end-page: 441 article-title: Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia publication-title: Biol Psychiatry – volume: 35 start-page: 2590 year: 2010 end-page: 2599 article-title: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia publication-title: Neuropsychopharmacology – volume: 65 start-page: 772 year: 2008 end-page: 784 article-title: Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia publication-title: Arch Gen Psychiatry – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 66 start-page: 811 year: 2009 end-page: 822 article-title: Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia publication-title: Arch Gen Psychiatry – volume: 57 start-page: 237 year: 2000 end-page: 245 article-title: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia publication-title: Arch Gen Psychiatry – volume: 66 start-page: 811 year: 2009 end-page: 822 article-title: Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia publication-title: Arch Gen Psychiatry – volume: 43 start-page: 114 year: 1986 end-page: 124 article-title: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence publication-title: Arch Gen Psychiatry – volume: 75 start-page: 457 year: 1989 end-page: 469 article-title: Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys publication-title: Exp Brain Res – volume: 97 start-page: 385 year: 2006 end-page: 396 article-title: Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo publication-title: J Neurochem – volume: 97 start-page: 385 year: 2006 end-page: 396 article-title: Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo publication-title: J Neurochem – volume: 13 start-page: 147 year: 2008 end-page: 161 article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia publication-title: Mol Psychiatry – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 24 start-page: 167 year: 2001 end-page: 202 article-title: An integrative theory of prefrontal cortex function publication-title: Annu Rev Neurosci – volume: 36 start-page: 316 year: 2011 end-page: 338 article-title: Cognitive control deficits in schizophrenia: mechanisms and meaning publication-title: Neuropsychopharmacology – volume: 6 start-page: 312 year: 2005 end-page: 324 article-title: Cortical inhibitory neurons and schizophrenia publication-title: Nat Rev Neurosci – volume: 66 start-page: 461 year: 2007 end-page: 468 article-title: RNA in brain disease: no longer just “the messenger in the middle.” publication-title: J Neuropathol Exp Neurol – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 34 start-page: 944 year: 2008 end-page: 961 article-title: GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia publication-title: Schizophr Bull – volume: 914 start-page: 81 year: 2001 end-page: 91 article-title: Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein publication-title: Brain Res – volume: 33 start-page: 912 year: 2007 end-page: 920 article-title: How should DSM-V criteria for schizophrenia include cognitive impairment? publication-title: Schizophr Bull – volume: 229 start-page: 891 year: 1996 end-page: 895 article-title: Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures publication-title: Biochem Biophys Res Commun – volume: 4 start-page: 40 year: 1994 end-page: 51 article-title: Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys publication-title: Cereb Cortex – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 68 start-page: 667 year: 2010 end-page: 670 article-title: Elevated gamma-aminobutyric acid levels in chronic schizophrenia publication-title: Biol Psychiatry – volume: 165 start-page: 479 year: 2008 end-page: 489 article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 94 start-page: 6496 year: 1997 end-page: 6499 article-title: Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 4 start-page: 40 year: 1994 end-page: 51 article-title: Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys publication-title: Cereb Cortex – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 18 start-page: 4244 year: 1998 end-page: 4254 article-title: Induced gamma-band activity during the delay of a visual short-term memory task in humans publication-title: J Neurosci – volume: 1240 start-page: 62 year: 2008 end-page: 72 article-title: An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections publication-title: Brain Res – volume: 25 start-page: 372 year: 2005 end-page: 383 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia publication-title: J Neurosci – volume: 1240 start-page: 62 year: 2008 end-page: 72 article-title: An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections publication-title: Brain Res – volume: 165 start-page: 479 year: 2008 end-page: 489 article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 34 start-page: 374 year: 2009 end-page: 389 article-title: Reduced dendritic spine density in auditory cortex of subjects with schizophrenia publication-title: Neuropsychopharmacology – volume: 959 start-page: 57 year: 2002 end-page: 65 article-title: Pigments in aging: an overview publication-title: Ann NY Acad Sci – volume: 23 start-page: 6315 year: 2003 end-page: 6326 article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia publication-title: J Neurosci – volume: 68 start-page: 667 year: 2010 end-page: 670 article-title: Elevated gamma-aminobutyric acid levels in chronic schizophrenia publication-title: Biol Psychiatry – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 112 start-page: 192 year: 2009 end-page: 193 article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study publication-title: Schizophr Res – volume: 20 start-page: 259 year: 2000 end-page: 269 article-title: Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain publication-title: J Chem Neuroanat – volume: 57 start-page: 1061 year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch Gen Psychiatry – volume: 57 start-page: 237 year: 2000 end-page: 245 article-title: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia publication-title: Arch Gen Psychiatry – volume: 30 start-page: 3777 year: 2010 end-page: 3781 article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression publication-title: J Neurosci – volume: 52 start-page: 258 year: 1995 end-page: 266 article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics publication-title: Arch Gen Psychiatry – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 24 start-page: 639 year: 2009 end-page: 645 article-title: Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia publication-title: Hum Psychopharmacol – volume: 33 start-page: e56 year: 2005 article-title: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces publication-title: Nucleic Acids Res – volume: 103 start-page: 19878 year: 2006 end-page: 19883 article-title: Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia publication-title: Proc Natl Acad Sci USA – ident: B6 doi: 10.1001/archpsyc.1986.01800020020004 – ident: B7 doi: 10.1523/JNEUROSCI.18-11-04244.1998 – ident: B15 doi: 10.1006/bbrc.1996.1898 – ident: B18 doi: 10.1001/archpsyc.57.11.1061 – ident: B2 doi: 10.1093/schbul/sbm046 – ident: B3 doi: 10.1038/npp.2010.156 – ident: B4 doi: 10.1146/annurev.neuro.24.1.167 – ident: B26 doi: 10.1016/j.brainres.2008.08.060 – ident: B11 doi: 10.1038/nrn1648 – volume-title: Two-Factor Index of Social Position year: 1965 ident: B33 – ident: B14 doi: 10.1073/pnas.94.12.6496 – ident: B25 doi: 10.1038/nature08002 – ident: B41 doi: 10.1007/BF00249897 – ident: B23 doi: 10.1001/archpsyc.57.3.237 – ident: B5 doi: 10.1001/archgenpsychiatry.2009.91 – ident: B32 doi: 10.1523/JNEUROSCI.4035-04.2005 – ident: B30 doi: 10.1001/archpsyc.65.7.772 – ident: B39 doi: 10.1002/hup.1070 – ident: B27 doi: 10.1176/appi.ajp.2007.07081223 – start-page: 202 volume-title: Neurobiology of Mental Illness year: 2008 ident: B21 – ident: B24 doi: 10.1523/JNEUROSCI.23-15-06315.2003 – ident: B1 doi: 10.1176/ajp.153.3.321 – ident: B29 doi: 10.1038/npp.2008.67 – ident: B22 doi: 10.1001/archpsyc.1995.03950160008002 – ident: B17 doi: 10.1093/cercor/4.1.40 – ident: B31 doi: 10.1016/S0891-0618(00)00105-8 – ident: B40 doi: 10.1016/j.biopsych.2010.09.038 – ident: B10 doi: 10.1093/schbul/sbn070 – ident: B35 doi: 10.1038/sj.mp.4002011 – ident: B9 doi: 10.1038/npp.2010.150 – ident: B37 doi: 10.1016/j.schres.2009.04.026 – ident: B13 doi: 10.1111/j.1471-4159.2006.03741.x – ident: B38 doi: 10.1523/JNEUROSCI.6158-09.2010 – ident: B8 doi: 10.1073/pnas.0609440103 – ident: B20 doi: 10.1111/j.1471-4159.1993.tb03206.x – ident: B34 doi: 10.1111/j.1749-6632.2002.tb02083.x – ident: B36 doi: 10.1016/j.biopsych.2010.05.016 – ident: B16 doi: 10.1007/s11920-010-0124-8 – ident: B19 doi: 10.1097/01.jnen.0000240474.27791.f3 – ident: B12 doi: 10.1016/S0006-8993(01)02778-0 – ident: B28 doi: 10.1093/nar/gni054 – reference: 21890799 - Am J Psychiatry. 2011 Sep;168(9):879-81. doi: 10.1176/appi.ajp.2011.11050694. |
| SSID | ssj0000372 |
| Score | 2.4869494 |
| Snippet | Depression was associated with increased inflammation as measured by elevated levels of interleukin-6 and high-sensitivity C-reactive protein in patients with... Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower expression... Objective: Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower... OBJECTIVE: Cognitive deficits in schizophrenia are associated with altered activity of the dorsolateral prefrontal cortex, which has been attributed to lower... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref appi |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 921 |
| SubjectTerms | Adult Adult and adolescent clinical studies Biological and medical sciences Blotting, Western Brain Cognition & reasoning Cognition Disorders - genetics Cognition Disorders - pathology Cohort Studies Enzymes Female gamma-Aminobutyric Acid - metabolism Gene expression Glutamate Decarboxylase - genetics Humans Male Medical sciences Microscopy, Fluorescence Middle Aged Neurons - metabolism Neurons - pathology Neuropsychology Parvalbumins - metabolism Prefrontal Cortex - enzymology Prefrontal Cortex - pathology Presynaptic Terminals Proteins Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Reference Values RNA, Messenger - genetics Schizophrenia Schizophrenia - genetics Schizophrenia - pathology |
| Title | Cortical Deficits of Glutamic Acid Decarboxylase 67 Expression in Schizophrenia: Clinical, Protein, and Cell Type-Specific Features |
| URI | http://dx.doi.org/10.1176/appi.ajp.2011.11010052 https://www.ncbi.nlm.nih.gov/pubmed/21632647 https://www.proquest.com/docview/888342478 https://www.proquest.com/docview/887757978 https://www.proquest.com/docview/907177656 https://pubmed.ncbi.nlm.nih.gov/PMC3273780 |
| Volume | 168 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5FRUJICPFuKFR74JaY1vZ6H9yspKVteKltpN4sP9YiVZVEaSIBV_4nv4UZr9ePEBHgYkW2N7v2fN6dmf1mhpDXh3kmcL_N0Uxoh7le7iitPYcLBsYAY5lMC7bFR34yZmdXwVWn87PBWlotkzfp941xJf8jVTgHcsUo2X-QbPWncAJ-g3zhCBKG41_JeDBbGFf0UGMiCEPLeAc9YpH5XphOkGWcxotk9vUbaMm6xwXmNjbU14LieNHk3KF3oMwTagobYw4Hk2MA3esDdPOh3eoUReuhxx4qkKtFSUO8roFX7QM1ElO0edXFvsf4HNRjE2ZzU5RCrOAUnsMcbxR8TH5imOGmMtin96OKjN-rPEThRXg8dsLh2dFpvbGBGvSo6ddAR61qcUTsQD_b0eGLW4NsPamroCgrXE_qXDbQqxpTtDIR2eVqr4y_5feFRBQZlOcYUHg9N6leQVNy0Y1eL52WLrC2olY8Rw_xzjEC8I4HZgxW2BiejmpNwReeNc_wAcoIduj7YHPPoDfghZYOdX8e3wIsclOHZZOhtM73bShQlw_Jg9LyoaGB8SPS0dPH5O6HktvxhPywaKYWzXSWU4tmimimLTRTLmiNZjqZ0haa31KL5T4tkdyngGOKOKYtHFOL46dkfHx0OThxyhIhThxwtnTyJMmywM-1yDPfd1kgPDeLXSmUG2vp-TpO1KHMsjzjSvPA05zl3E98Fru-lirzn5Gd6WyqdwkVie9JKVnisZxhUVWhlM5Ag5ZpLjPudUkf331Ufji3UWE-Cx4VZ0FUEYoqsqLqksDKKErLdPtY9eVma7uDqt3cJJzZ2mK_BYGqmUVfl-xZTNSjh0f1mceE7BJaXYWlBfcL46merfAWIQKh_nSLQneQAJuwS54bjNW9g6UH1pboEtFCX3UDJrZvX5lOvhQJ7n2wqYQ8fLHtwfbIvXrmeEl2louVfgU2wjLZLz60X40rEq4 |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cortical+Deficits+of+Glutamic+Acid+Decarboxylase+67+Expression+in+Schizophrenia%3A+Clinical%2C+Protein%2C+and+Cell+Type-Specific+Features&rft.jtitle=The+American+journal+of+psychiatry&rft.au=CURLEY%2C+Allison+A&rft.au=ARION%2C+Dominique&rft.au=VOLK%2C+David+W&rft.au=ASAFU-ADJEI%2C+Josephine+K&rft.date=2011-09-01&rft.pub=American+Psychiatric+Association&rft.issn=0002-953X&rft.volume=168&rft.issue=9&rft.spage=921&rft.epage=929&rft_id=info:doi/10.1176%2Fappi.ajp.2011.11010052&rft.externalDBID=n%2Fa&rft.externalDocID=24484610 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon |